{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:51:59Z","timestamp":1767991919406,"version":"3.49.0"},"reference-count":77,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tokyo Metropolitan Government","award":["H260301002"],"award-info":[{"award-number":["H260301002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Sarcopenia, which represents the degenerative and systemic loss of skeletal muscle mass, is a multifactorial syndrome caused by various clinical conditions. Sarcopenia reflects not only frailty and poor general health status, but also the possible presence of advanced or progressive cancer or cancer cachexia. Therefore, sarcopenia affects the management of cancer-bearing patients, including those with urothelial carcinoma. Recently, growing evidence has shown that sarcopenia is significantly associated with higher rates of treatment-related complications and worse prognosis in patients with urothelial carcinoma, including muscle-invasive bladder cancer, upper tract urothelial carcinoma, and advanced urothelial carcinoma. Moreover, several studies reported that a post-therapeutic increase in skeletal muscle mass predicts favorable prognosis in urothelial carcinoma patients. To further explore the role of sarcopenia in the management of urothelial carcinoma patients, comprehensive understanding of its pathophysiology is vital. In this article, we reviewed the metabolic and molecular basis of cancer cachexia and sarcopenia. From this viewpoint, we discussed the possible mechanism of changes in skeletal muscle mass during the course of treatment.<\/jats:p>","DOI":"10.3390\/ijms20030760","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T03:18:20Z","timestamp":1549941500000},"page":"760","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma"],"prefix":"10.3390","volume":"20","author":[{"given":"Hiroshi","family":"Fukushima","sequence":"first","affiliation":[{"name":"Department of Urology, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan"},{"name":"Department of Urology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7888-0085","authenticated-orcid":false,"given":"Fumitaka","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer","volume":"71","author":"Lebret","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0022-5347(05)66440-3","article-title":"Cystectomy for bladder cancer: A contemporary series","volume":"165","author":"Dalbagni","year":"2001","journal-title":"J. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.juro.2012.10.057","article-title":"Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: Development of an optimized postoperative nomogram using decision curve analysis","volume":"189","author":"Roupret","year":"2013","journal-title":"J. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1200\/JCO.2011.38.6979","article-title":"Randomized phase III study comparing paclitaxel\/cisplatin\/gemcitabine and gemcitabine\/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987","volume":"30","author":"Bellmunt","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(17)30007-4","article-title":"Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): A non-randomised, open-label, phase 1b study","volume":"18","author":"Plimack","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Baeyens","year":"2010","journal-title":"Age Ageing"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11005\/jbm.2013.20.1.1","article-title":"Sarcopenia: Definition, epidemiology, and pathophysiology","volume":"20","author":"Kim","year":"2013","journal-title":"J. Bone Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jcsm.12073","article-title":"Sarcopenia and mortality among a population-based sample of community-dwelling older adults","volume":"7","author":"Brown","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ageing\/afs194","article-title":"Sarcopenia and mortality risk in frail older persons aged 80 years and older: Results from ilSIRENTE study","volume":"42","author":"Landi","year":"2013","journal-title":"Age Ageing"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1017\/BJN20061943","article-title":"Sarcopenia is predictive of nosocomial infection in care of the elderly","volume":"96","author":"Cosqueric","year":"2006","journal-title":"Br. J. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3961\/jpmph.15.055","article-title":"Associations of Sarcopenia and Sarcopenic Obesity with Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength","volume":"49","author":"Lee","year":"2016","journal-title":"J. Prev. Med. Public Health"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00198-014-2745-y","article-title":"Early-stage chronic kidney disease, insulin resistance, and osteoporosis as risk factors of sarcopenia in aged population: The fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2008\u20132009","volume":"25","author":"Kim","year":"2014","journal-title":"Osteoporos. Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3346\/jkms.2015.30.3.264","article-title":"Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score","volume":"30","author":"Kim","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/bjs.9258","article-title":"Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma","volume":"100","author":"Harimoto","year":"2013","journal-title":"Br. J. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/dote.12381","article-title":"Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma","volume":"29","author":"Harada","year":"2016","journal-title":"Dis. Esophagus"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jcsm.12115","article-title":"Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"7","author":"Go","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1245\/s10434-011-1976-9","article-title":"Sarcopenia as a prognostic factor among patients with stage III melanoma","volume":"18","author":"Sabel","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.juro.2015.08.072","article-title":"Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer","volume":"195","author":"Psutka","year":"2016","journal-title":"J. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.juro.2015.08.071","article-title":"Prognostic Significance of Sarcopenia in Patients with Metastatic Renal Cell Carcinoma","volume":"195","author":"Fukushima","year":"2016","journal-title":"J. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/14737140.2017.1301209","article-title":"Impact of sarcopenia in the management of urological cancer patients","volume":"17","author":"Fukushima","year":"2017","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejso.2014.11.040","article-title":"Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer","volume":"41","author":"Tan","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Fukushima, H., Takemura, K., Suzuki, H., and Koga, F. (2018). Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer. Int. J. Mol. Sci., 19.","DOI":"10.20944\/preprints201808.0077.v1"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1002\/cncr.28798","article-title":"Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality","volume":"120","author":"Psutka","year":"2014","journal-title":"Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.juro.2013.12.047","article-title":"Sarcopenia as a predictor of complications and survival following radical cystectomy","volume":"191","author":"Smith","year":"2014","journal-title":"J. Urol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1002\/cam4.795","article-title":"Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy","volume":"5","author":"Fukushima","year":"2016","journal-title":"Cancer Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10147-016-1021-x","article-title":"Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: A retrospective multi-institution study","volume":"22","author":"Ishihara","year":"2017","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Fukushima, H., Yokoyama, M., Nakanishi, Y., Tobisu, K., and Koga, F. (2015). Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0115895"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"156.e9","DOI":"10.1016\/j.urolonc.2017.09.016","article-title":"Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy","volume":"36","author":"Fukushima","year":"2018","journal-title":"Urol. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4161\/15384047.2014.987075","article-title":"Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice","volume":"16","author":"Kliewer","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argiles","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: Mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1113\/jphysiol.2006.116715","article-title":"Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy","volume":"576","author":"Leger","year":"2006","journal-title":"J. Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00109-008-0373-8","article-title":"Nuclear factor-kappa B signaling in skeletal muscle atrophy","volume":"86","author":"Li","year":"2008","journal-title":"J. Mol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","article-title":"NF-kB-induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia","volume":"289","author":"Guttridge","year":"2000","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2017.03.009","article-title":"Skeletal muscle autophagy and its role in sarcopenia and organismal aging","volume":"34","author":"Jiao","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-011-0030-x","article-title":"Intramyocellular lipid droplets increase with progression of cachexia in cancer patients","volume":"2","author":"Stephens","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1054\/bjoc.2001.1700","article-title":"Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia","volume":"84","author":"Belizario","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13539-012-0071-9","article-title":"Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency","volume":"3","author":"Julienne","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.exger.2006.06.053","article-title":"Aging increases the susceptibility of skeletal muscle derived satellite cells to apoptosis","volume":"41","author":"Jejurikar","year":"2006","journal-title":"Exp. Gerontol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nm.4093","article-title":"Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia","volume":"22","author":"Fukawa","year":"2016","journal-title":"Nat. Med."},{"key":"ref_50","first-page":"R1165","article-title":"NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes","volume":"279","author":"Li","year":"2000","journal-title":"Am. J. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance non-small cell lung cancer patients (N01C9)","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0022-5347(05)64745-3","article-title":"Interleukin-6 production by human bladder tumor cell lines is up-regulated by bacillus Calmette-Guerin through nuclear factor-kB and Ap-1 via an immediate early pathway","volume":"168","author":"Chen","year":"2002","journal-title":"J. Urol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0022-5347(05)67678-1","article-title":"Autocrine IL-6 production by human transitional carcinoma cells upregulates expression of the alpha5beta1 firbonectin receptor","volume":"163","author":"Zhang","year":"2000","journal-title":"J. Urol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2063179","DOI":"10.1155\/2018\/2063179","article-title":"Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia","volume":"2018","author":"Abrigo","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4350965","DOI":"10.1155\/2016\/4350965","article-title":"ROS and ROS-Mediated Cellular Signaling","volume":"2016","author":"Zhang","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","article-title":"Sarcopenic obesity in older adults: Aetiology, epidemiology and treatment strategies","volume":"14","author":"Batsis","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MCO.0b013e328312c37d","article-title":"Sarcopenic obesity: Definition, cause and consequences","volume":"11","author":"Stenholm","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.clgc.2016.08.004","article-title":"Postoperative Changes in Skeletal Muscle Mass Predict Survival of Patients with Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy","volume":"15","author":"Fukushima","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/0284186X.2014.953259","article-title":"Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer","volume":"54","author":"Stene","year":"2015","journal-title":"Acta Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jcsm.12107","article-title":"Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients","volume":"7","author":"Rutten","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11523-018-0600-3","article-title":"Effect of Changes in Skeletal Muscle Mass on Oncological Outcomes During First-Line Sunitinib Therapy for Metastatic Renal Cell Carcinoma","volume":"13","author":"Ishihara","year":"2018","journal-title":"Target Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Miyake, M., Morizawa, Y., Hori, S., Marugami, N., Shimada, K., Gotoh, D., Tatsumi, Y., Nakai, Y., Inoue, T., and Anai, S. (2017). Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3325-2"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1369\/0022155411426780","article-title":"The skeletal muscle satellite cell: Still young and fascinating at 50","volume":"59","year":"2011","journal-title":"J. Histochem. Cytochem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-0838.2003.20285.x","article-title":"Satellite cells and training in the elderly","volume":"13","author":"Thornell","year":"2003","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biocel.2009.09.021","article-title":"Satellite cells are increasingly refractory to activation by nitric oxide and stretch in aged mouse-muscle cultures","volume":"42","author":"Leiter","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0531-5565(02)00129-8","article-title":"Human skeletal muscle satellite cells: Aging, oxidative stress and the mitotic clock","volume":"37","author":"Renault","year":"2002","journal-title":"Exp. Gerontol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.18632\/aging.101098","article-title":"Age-associated NF-kB signaling in myofibers alters the satellite cell niche and re-strains muscle stem cell function","volume":"8","author":"Oh","year":"2016","journal-title":"Aging"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.yexcr.2007.09.012","article-title":"Myostatin signals through Pax7 to regulate satellite cell self-renewal","volume":"314","author":"McFarlane","year":"2008","journal-title":"Exp. Cell Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00520-008-0403-7","article-title":"A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)","volume":"16","author":"Berk","year":"2008","journal-title":"Support. Care Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"316943","DOI":"10.1155\/2012\/316943","article-title":"Rationale for antioxidant supplementation in sarcopenia","volume":"2012","author":"Cerullo","year":"2012","journal-title":"J. Aging Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-012-0087-1","article-title":"Cancer cachexia: Impact, mechanisms and emerging treatments","volume":"4","author":"Vaughan","year":"2013","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Amor, M., Itariu, B.K., Moreno-Viedma, V., Keindl, M., Jurets, A., Prager, G., Langer, F., Grablowitz, V., Zeyda, M., and Stulnig, T.M. (2018). Serum Myostatin is Upregulated in Obesity and Correlates with Insulin Resistance in Humans. Exp. Clin. Endocrinol. Diabetes.","DOI":"10.1055\/a-0641-5546"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Beluzi, M., Peres, S.B., Henriques, F.S., Sertie, R.A., Franco, F.O., Santos, K.B., Knobl, P., Andreotti, S., Shida, C.S., and Neves, R.X. (2015). Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: Possible anti-cachectic effect. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122660"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/db06-1566","article-title":"Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt\/mammalian target of rapamycin signaling","volume":"56","author":"Fujita","year":"2007","journal-title":"Diabetes"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cmet.2016.01.011","article-title":"Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution","volume":"23","author":"Pedersen","year":"2016","journal-title":"Cell Metab."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-16-3125","article-title":"Exercise-Induced Catecholamines Activate the Hippo Tumor Suppressor Pathway to Reduce Risks of Breast Cancer Development","volume":"77","author":"Dethlefsen","year":"2017","journal-title":"Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/3\/760\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:31:06Z","timestamp":1760185866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/3\/760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":77,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2]]}},"alternative-id":["ijms20030760"],"URL":"https:\/\/doi.org\/10.3390\/ijms20030760","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]}}}